European researchers and clinicians are working hand in hand to unveil the mechanisms leading to back pain, likely the most widespread chronic pathology among humans .

European scientists set up new therapeutic approaches to tackle specific Lysosomal Storage Disorders: a new drug combination and enzyme replacement therapy against Pompe disease and gene therapy against MPS V I (Mucopolysaccharidosis VI).

Juliet Ross is suffering from Huntington’s Disease, a rare neurological disorder that affects one in 10.000 people. Due to a genetic defect, her body produces a toxic protein that damages neurons in her brain .

This test evaluates the presence of certain proteins in blood samples of patients. Sabine Bahn from the University of Cambridge says that the new test is able to diagnose schizophrenia with a certainty of 83% and depression with a certainty of about 90% .

In Europe, whooping cough ( Pertussis ) is in the increase, with more than 20.000 cases reported annually . Often infants fall victim to the disease, where it can be life-threatening.

HIV is still plaguing humanity with 35 million infected people worldwide. Antiretroviral drugs do slow down the progression of the disease but at a high cost and with long term toxicity.

November 18 th is the annual European Antibiotic Awareness Day . Its purpose is to highlight the increase of bacterial resistance to antibiotics on the continent .

It is a damning neologism of our age, a new word combining the threat of two major health problems of epidemic-like proportions. In Europe alone, around 33 million adults are expected to be suffering from type-2 diabetes by 2010.

“We need our own kind of Kyoto treaty for antibiotics: the point is, we should treat antibiotics as a non-renewable source”, says professor Antonio Cassone, research director of the Italian Istituto Superiore di Sanità.